國立虎尾科技大學 |

Pharmacotherapy in aortic disease

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Pharmacotherapy in aortic disease/ edited by Arturo Evangelista, Christoph A. Nienaber.
other author:	Evangelista, Arturo.
Published:	Cham :Springer International Publishing : : 2015.,
Description:	xii, 269 p. :ill., digital ; : 24 cm.;
Contained By:	Springer eBooks
Subject:	Aorta - Diseases -
Online resource:	http://dx.doi.org/10.1007/978-3-319-09555-4
ISBN:	9783319095554 (electronic bk.)

Pharmacotherapy in aortic disease
Pharmacotherapy in aortic disease[electronic resource] /edited by Arturo Evangelista, Christoph A. Nienaber. - Cham :Springer International Publishing :2015. - xii, 269 p. :ill., digital ;24 cm. - Current cardiovascular therapy ;7. - Current cardiovascular therapy ;5..

Aortic atherosclerosis as an embolic source -- Aortitis -- Aortic aneurysm -- Marfan Syndrome -- Acute Aortic Syndrome -- Chronic aortic dissection.

This book is driven by the considerable progress made by novel imaging techniques in understanding the pathophysiology and evolution of aortic disease and its diagnosis. Despite the lack of symptoms in stable conditions, most aortic diseases have a high morbidity and mortality. New therapeutic strategies such as endovascular treatment and surgical techniques have appeared to improve conventional surgery in advanced phases of the disease, but until recently, medical treatment has focused on the control of cardiovascular risk factors using beta-blockers to reduce aortic wall stress by reducing blood pressure and heart rate. Pharmacotherapy in Aortic Disease updates the reader on the new medical treatment that are changing the natural history of these diseases. Leading experts have created a critical in-depth, yet concise, analysis of the available medical treatments for different aortic disease entities. Both basic research studies and clinical trials discussed in this book serve as a base for improving therapeutic management, delaying the need for surgery, and prolonging survival in these patients.

ISBN: 9783319095554 (electronic bk.)

Standard No.: 10.1007/978-3-319-09555-4doiSubjects--Topical Terms:

1064621
Aorta
--Diseases

LC Class. No.: RC691

Dewey Class. No.: 616.138

Pharmacotherapy in aortic disease
LDR:02241nam a2200325 a 4500 001 835384
003 DE-He213
005 20150723153717.0
006 m d
007 cr nn 008maaau
008 160421s2015 gw s 0 eng d
020 $a 9783319095554 (electronic bk.)
020 $a 9783319095547 (paper)
024 7 $a 10.1007/978-3-319-09555-4 $2 doi
035 $a 978-3-319-09555-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RC691
072 7 $a MJD $2 bicssc
072 7 $a MED010000 $2 bisacsh
082 0 4 $a 616.138 $2 23
090 $a RC691 $b .P536 2015
245 0 0 $a Pharmacotherapy in aortic disease $h [electronic resource] / $c edited by Arturo Evangelista, Christoph A. Nienaber.
260 $a Cham : $c 2015. $b Springer International Publishing : $b Imprint: Springer,
300 $a xii, 269 p. : $b ill., digital ; $c 24 cm.
490 1 $a Current cardiovascular therapy ; $v 7
505 0 $a Aortic atherosclerosis as an embolic source -- Aortitis -- Aortic aneurysm -- Marfan Syndrome -- Acute Aortic Syndrome -- Chronic aortic dissection.
520 $a This book is driven by the considerable progress made by novel imaging techniques in understanding the pathophysiology and evolution of aortic disease and its diagnosis. Despite the lack of symptoms in stable conditions, most aortic diseases have a high morbidity and mortality. New therapeutic strategies such as endovascular treatment and surgical techniques have appeared to improve conventional surgery in advanced phases of the disease, but until recently, medical treatment has focused on the control of cardiovascular risk factors using beta-blockers to reduce aortic wall stress by reducing blood pressure and heart rate. Pharmacotherapy in Aortic Disease updates the reader on the new medical treatment that are changing the natural history of these diseases. Leading experts have created a critical in-depth, yet concise, analysis of the available medical treatments for different aortic disease entities. Both basic research studies and clinical trials discussed in this book serve as a base for improving therapeutic management, delaying the need for surgery, and prolonging survival in these patients.
650 0 $a Aorta $x Diseases $x Chemotherapy. $3 1064621
650 0 $a Cardiovascular pharmacology. $3 1021444
650 1 4 $a Medicine & Public Health. $3 593949
650 2 4 $a Cardiology. $3 593957
650 2 4 $a Pharmacotherapy. $3 973587
650 2 4 $a Cardiac Surgery. $3 673715
700 1 $a Evangelista, Arturo. $3 1064619
700 1 $a Nienaber, Christoph A. $3 1064620
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer eBooks
830 0 $a Current cardiovascular therapy ; $v 5. $3 1063597
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-09555-4
950 $a Medicine (Springer-11650)